ArticleJournal of neuro-oncology2018

Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.

Jinquan Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.